Naleya Genomics Ngi

Naleya Genomik Indonesia (NGI) is a biotechnology company driving the future of precision health in Indonesia. As one of the country’s leading genomics laboratories, we provide high-quality, affordable, and clinically actionable genetic testing in reproductive health, rare diseases, and inherited conditions - powered by advanced infrastructure and international technology transfer. We collaborate with hospitals, government institutions, and academic partners to localize cutting-edge biotechnology, accelerate clinical adoption, and support Indonesia’s national healthcare transformation. NGI is building a robust, scalable, and trusted genomics ecosystem - from clinic to community - with a mission to make precision healthcare accessible, sustainable, and impactful for all Indonesians. From Indonesia. By Indonesia. For Indonesia.